These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1825847)

  • 1. Perfluorinated analogues of poison ivy allergens. Synthesis and skin tolerogenic activity in mice.
    Fraginals R; Schaeffer M; Stampf JL; Benezra C
    J Med Chem; 1991 Mar; 34(3):1024-7. PubMed ID: 1825847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Saturated analogues of poison ivy allergens. Synthesis of trans,trans- and cis,trans-3-alkyl-1,2-cyclohexanediols and sensitizing properties in allergic contact dermatitis.
    Lepoittevin JP; Benezra C
    J Med Chem; 1986 Feb; 29(2):287-91. PubMed ID: 2936885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of tolerance to poison ivy urushiol in the guinea pig by epicutaneous application of the structural analog 5-methyl-3-n-pentadecylcatechol.
    Stampf JL; Benezra C; Byers V; Castagnoli N
    J Invest Dermatol; 1986 May; 86(5):535-8. PubMed ID: 2943824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A murine model system for contact sensitization to poison oak or ivy urushiol components.
    Dunn IS; Liberato DJ; Dennick RG; Castagnoli N; Byers VS
    Cell Immunol; 1982 Apr; 68(2):377-88. PubMed ID: 6178516
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of chemical reactivity of urushiol-type haptens on sensitization and the induction of tolerance.
    Dunn IS; Liberato DJ; Castagnoli N; Byers VS
    Cell Immunol; 1986 Jan; 97(1):189-96. PubMed ID: 3742608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the contact sensitivity response to urushiol with anti-urushiol monoclonal antibody ALG 991.
    Baldwin RW; Clegg JA; Curran AC; Austin EB; Khan T; Ma Y; Gunn B; Hudecz F; Byers VS; Lepoittevin JP; Price MR
    Arch Dermatol Res; 1999 Dec; 291(12):652-8. PubMed ID: 10651166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed contact sensitivity to catechols. 3. The relationship of side-chain length to sensitizing potency of catechols chemically related to the active principles of poison ivy.
    Baer H; Watkins RC; Kurtz AP; Byck JS; Dawson CR
    J Immunol; 1967 Aug; 99(2):370-5. PubMed ID: 4226616
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunologic studies of poisonous Anacardiaceae: I. Production of tolerance and desensitization to poison Ivy and oak urushiols using esterified urushiol derivatives in guinea pigs.
    Watson ES; Murphy JC; Wirth PW; Waller CW; Elsohly MA
    J Invest Dermatol; 1981 Mar; 76(3):164-70. PubMed ID: 6453903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analogues of poison ivy urushiol. Synthesis and biological activity of disubstituted n-alkylbenzenes.
    ElSohly MA; Adawadkar PD; Benigni DA; Watson ES; Little TL
    J Med Chem; 1986 May; 29(5):606-11. PubMed ID: 2939241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on poison ivy. In vitro lymphocyte transformation by urushiol-protein conjugates.
    Dupuis G
    Br J Dermatol; 1979 Dec; 101(6):617-24. PubMed ID: 161173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro studies of poison oak immunity. II. Effect of urushiol analogues on the human in vitro response.
    Byers VS; Castagnoli N; Epstein WL
    J Clin Invest; 1979 Nov; 64(5):1449-56. PubMed ID: 315415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The synthesis of compounds structurally related to poison ivy Urushiol. 4,5-dimethyl-3-pentadecylcatechol.
    Byck JS; Dawson CR
    J Org Chem; 1967 Apr; 32(4):1084-8. PubMed ID: 4227456
    [No Abstract]   [Full Text] [Related]  

  • 13. Preservation of allergic contact dermatitis to poison ivy (urushiol) in late HIV disease. The implications and relevance to immunotherapy with contact allergens.
    Smith KJ; Skelton HG; Nelson A; Wagner KF; Hackley BE
    Dermatology; 1997; 195(2):145-9. PubMed ID: 9310722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The poison ivy picker of Pennypack Park: the continuing saga of poison ivy.
    Epstein WL
    J Invest Dermatol; 1987 Mar; 88(3 Suppl):7s-11s. PubMed ID: 2950182
    [No Abstract]   [Full Text] [Related]  

  • 15. Synthesis of compounds structurally related to poison ivy urushiol. 3. 3-n-Pentadecylcatechol and 3-n-alkylcatechols of varying side-chain length.
    Kurtz AP; Dawson CR
    J Med Chem; 1971 Aug; 14(8):729-32. PubMed ID: 4107134
    [No Abstract]   [Full Text] [Related]  

  • 16. Liposomes containing 3-n-pentadecylcatechol induce tolerance to toxicodendron.
    Colby SL; Artis WM; Rietschel RL
    J Invest Dermatol; 1983 Mar; 80(3):145-9. PubMed ID: 6827123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occupational poison ivy and oak dermatitis.
    Epstein WL
    Dermatol Clin; 1994 Jul; 12(3):511-6. PubMed ID: 7923948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptome profiling reveals Th2 bias and identifies endogenous itch mediators in poison ivy contact dermatitis.
    Liu B; Tai Y; Liu B; Caceres AI; Yin C; Jordt SE
    JCI Insight; 2019 Jun; 5(14):. PubMed ID: 31184997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed contact sensitivity to catechols. II. Cutaneous toxicity of catechols chemically related to the active principles of poison ivy.
    Baer H; Watkins RC; Kurtz AP; Byck JS; Dawson CR
    J Immunol; 1967 Aug; 99(2):365-9. PubMed ID: 4226615
    [No Abstract]   [Full Text] [Related]  

  • 20. Nonenzymic spectrophotometric determination of potential poison ivy cross-reactors.
    Quattrone AJ
    Clin Chem; 1977 Mar; 23(3):571-5. PubMed ID: 138495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.